BIOLINERX LTD-SPONS ADR (BLRX)
US09071M2052 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 3.15M | 3.62M | 8.46M | N/A | N/A | |||
| Cash Equivalents | N/A | N/A | N/A | 16.83M | 5.30M | |||
| Marketable Securities | 39.84M | 47.46M | 48.67M | 5.76M | 22.19M | |||
| Receivables | 1.19M | 721.00K | 142.00K | 141.00K | 613.00K | |||
| Inventories | 1.95M | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 1.05M | 198.00K | 127.00K | 152.00K | 108.00K | |||
| Total Current Assets | 47.18M | 52.00M | 57.40M | 22.88M | 28.21M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.89M | 2.50M | 2.28M | 2.70M | 3.47M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | 14.85M | 21.89M | 21.70M | 21.71M | 21.89M | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Non-Current Assets | 16.74M | 24.38M | 23.99M | 24.41M | 25.36M | |||
| TOTAL ASSETS | 63.92M | 76.38M | 81.39M | 47.29M | 53.57M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 3.67M | 1.97M | 2.92M | 3.28M | 2.89M | |||
| Accrued Expenses | 3.27M | 1.66M | 1.23M | N/A | N/A | |||
| Accounts Payable | 10.87M | 6.97M | 5.57M | 7.36M | 9.07M | |||
| Other Current Liabilities | 13.04M | 84.00K | 2.00K | N/A | N/A | |||
| Total Current Liabilities | 30.85M | 10.68M | 9.72M | 10.64M | 11.97M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 7.92M | 10.36M | 1.73M | 4.40M | 7.56M | |||
| Other Non-Current Liabilities | 11.93M | 4.51M | 1.86M | 10.22M | 658.00K | |||
| Total Non-Current Liabilities | 19.85M | 14.86M | 3.58M | 14.62M | 8.22M | |||
| TOTAL LIABILITIES | 50.70M | 25.54M | 13.30M | 25.26M | 20.19M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -372.20M | -313.82M | -290.91M | -265.67M | -235.83M | |||
| Additional Paid In Capital | 355.48M | 338.98M | 339.35M | 279.24M | 265.94M | |||
| Common Shares | 31.36M | 27.10M | 21.07M | 9.87M | 4.69M | |||
| Other Shareholders' Equity | -1.42M | -1.42M | -1.42M | -1.42M | -1.42M | |||
| Shares Outstanding | 80.54M | 68.42M | 53.01M | 25.88M | 12.70M | |||
| Tangible Book Value per Share | -0.00 | 0.03 | 0.06 | 0.00 | 0.07 | |||
| Total Shareholders' Equity | 13.22M | 50.84M | 68.09M | 22.03M | 33.38M | |||
| TOTAL LIABILITIES AND EQUITY | 63.92M | 76.38M | 81.39M | 47.29M | 53.57M | |||
| Statistics | ||||||||
| Debt/Equity | 0.60 | 0.20 | 0.03 | 0.20 | 0.23 | |||
| Current Ratio | 1.53 | 4.87 | 5.91 | 2.15 | 2.36 | |||
| Return On Assets (ROA) | -94.82% | -32.67% | -33.24% | -63.48% | -47.50% | |||
| Return On Equity (ROE) | -458.40% | -49.08% | -39.73% | -136.27% | -76.23% | |||
All data in USD